Acceptance Factors and Psychological Investigation of Clinical Trials in Cancer Patients
- PMID: 38046475
- PMCID: PMC10691887
- DOI: 10.1155/2023/5617575
Acceptance Factors and Psychological Investigation of Clinical Trials in Cancer Patients
Abstract
Aim: To understand the degree of oncology patients' awareness of drug clinical trials and oncology patients' willingness to participate in drug clinical trials and the factors influencing them.
Methods: The differences in the relevant variables of patients' willingness to accept clinical trials were analyzed, and a descriptive analysis was done for the measurement data (mean and standard deviation). Pearson's correlation coefficient analysis was used to examine the correlation between willingness and the demographic variables. Stepwise regression analysis was used to explore the influencing factors of patients' willingness to accept clinical trials.
Results: There were no statistical differences in age, gender, education level, marital status, place of residence, monthly income, medical payment method, and treatment time (P > 0.05). Patients' willingness to accept drug clinical trials differed in their cognitive degree of clinical drug trials (P = 0.002). Patients' willingness to accept drug clinical trials differed in their experience in clinical trials (P < 0.001). The correlation difference was statistically significant. The willingness to accept drug clinical trials was negatively correlated with treatment time (R = -0.16, P < 0.05) and positively correlated with awareness of clinical trials and whether they had been subjects (R = 0.16 and 0.43, P < 0.05). Multiple regression analysis showed that patients' willingness was directly influenced by age, treatment time, and whether they had been subjects (F = 21.315, P < 0.001).
Conclusion: Age, treatment time, and whether they had been subjects were the direct influencing factors of patients' willingness. This study pointed out that hospitals should do a good job in the publicity of clinical trials of new drugs, expand publicity channels, increase publicity efforts, improve the awareness of clinical trials of the masses, and promote the enthusiasm of the masses to participate in clinical trials of drugs.
Copyright © 2023 Jiangjie Sun et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate.Cancer Res Treat. 2017 Oct;49(4):1033-1043. doi: 10.4143/crt.2016.413. Epub 2017 Apr 7. Cancer Res Treat. 2017. PMID: 28392549 Free PMC article.
-
Correlation between patients' power distance and their willingness to participate in patients' safety: A cross-sectional study.J Nurs Manag. 2022 Jul;30(5):1345-1354. doi: 10.1111/jonm.13601. Epub 2022 Apr 21. J Nurs Manag. 2022. PMID: 35312133
-
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives.Br J Cancer. 2008 Nov 18;99(10):1593-9. doi: 10.1038/sj.bjc.6604750. Br J Cancer. 2008. PMID: 19002181 Free PMC article.
-
Cancer patients' perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis.J Clin Nurs. 2019 Jul;28(13-14):2443-2461. doi: 10.1111/jocn.14785. Epub 2019 Mar 3. J Clin Nurs. 2019. PMID: 30673153 Review.
-
Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Aug 28. Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Aug 28. PMID: 25834875 Free Books & Documents. Review.
References
-
- Liu Z. C., Li Z. X., Zhang Y., et al. Interpretation on the report of global cancer statistics 2020. Journal of Multidisciplinary Cancer Management . 2021;7(2):p. 14.
-
- Weorld Health Organization. Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. February 2022, https://www.who.int/data/gho/data/themes/mortality-andglobal-health-esti....
MeSH terms
LinkOut - more resources
Full Text Sources
Medical